#Canada #Toronto #Imaging Technology #Perimeter AI #OCT-Tissue

Perimeter Medical Imaging Introduces Innovative OCT-Tissue Registry

In a significant milestone for medical imaging, Perimeter Medical Imaging AI, Inc. has announced the launch of the OCT-Tissue Surveillance Registry. This initiative is set to collect thousands of images and surgical data, enabling the company to refine its advanced imaging technology. Designed to enhance surgical outcomes, the registry will aid in the development of a sophisticated artificial intelligence (AI) deep-learning model for Perimeter's next-generation imaging systems.

Dr. Jennifer Tittensor, a general surgeon at Timpanogos Regional Hospital, has been an early contributor to the registry. Having utilized Perimeter's Optical Coherence Tomography (OCT) technology in over 120 surgeries, she highlighted the tool's vital role in real-time tissue assessment. By allowing surgeons to visualize margins during operations, this technology can minimize the chances of requiring additional surgeries due to leftover cancerous tissues.

The power of Perimeter’s S-Series OCT lies in its patented wide-field imaging capabilities that provide ultra-high-resolution visuals for surgeons during surgical procedures. The company is currently working on the investigational B-Series OCT, which includes ImgAssist AI 2.0. This next-gen platform is undergoing premarket approval by the U.S. Food and Drug Administration (FDA), aiming to improve the detection of suspicious tissues in breast-conserving surgeries.

CEO Adrian Mendes expressed optimism about the registry, stating, "This initiative presents a unique opportunity for both patients and surgeons to elevate the standard of clinical care." The data collected can help create a vast array of images that will enhance the training of their AI algorithms, ultimately aiding doctors in offering personalized care.

Developing robust AI technology for medical applications brings its own challenges, particularly in compiling a diverse dataset that encompasses various patient demographics. To tackle this, Perimeter has made extensive use of millions of proprietary OCT images depicting both healthy and cancerous tissues to train its algorithms. The establishment of the OCT-Tissue Registry will now allow the integration of real-world clinical data and images, making the AI model even more advanced.

Surgeons participating in the registry will have the opportunity to contribute both contemporary and retrospective data, which will be essential in monitoring surgical results over time and will assist in further refining the imaging technology.

For those interested in joining this groundbreaking effort, Perimeter invites inquiries regarding participation in the OCT-Tissue Registry. They can be contacted through their Clinical Affairs department via email at clinicalaffairs@perimeterai.com.

About Perimeter Medical Imaging AI, Inc.

Positioned in both Toronto, Canada, and Dallas, Texas, Perimeter Medical Imaging AI is at the forefront of transforming cancer surgery through innovative imaging solutions. Their FDA-cleared Perimeter S-Series OCT system is already enhancing surgical procedures across the U.S., offering real-time imaging of excised tissues down to the cellular level. The forthcoming Perimeter B-Series, equipped with ImgAssist AI, intends to revolutionize surgical practices with its advanced capabilities, and clinical trials have already begun with support from substantial funding.

In summary, Perimeter's launch of the OCT-Tissue Registry marks a progressive step towards bettering surgical outcomes in cancer treatment. By relying on a diverse set of data, the company aims to refine its technology and ultimately reduce the burden of secondary surgeries for patients fighting cancer. The commitment to collaboration with medical professionals will undoubtedly yield significant advancements in the healthcare landscape, making future surgeries safer and more efficient.